Back to top
more

ARK Genomic Revolution ETF: (ARKG)

(Delayed Data from NYSE MKT (ex. AMEX)) As of May 22, 2026 04:00 PM ET

$30.69 USD

30.685
2,056,309

+1.15 (3.88%)

Volume: 2,056,309

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $30.55 -0.14 (-0.44 %) 7:58 PM ET

Zacks News

Sweta Killa headshot

10 ETFs Up More Than 30% in a Month

The stabilization in the spread of the disease, hopes for re-opening of the economy anytime soon, and increased progress of drugmakers' to develop COVID-19 treatment has boosted confidence in the stock market.

Sanghamitra Saha headshot

Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Neena Mishra headshot

Why Biotech ETFs are Surging to New Highs

increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

Sweta Jaiswal, FRM headshot

A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

Sweta Killa headshot

Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

Zacks Equity Research

The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

Kevin Cook headshot

Why Gold is Headed to Zero -- And What You Should Buy Instead

In 2026, NASA mission Psyche will explore an asteroid that could hold over $5,000 quadrillion in gold

Sweta Jaiswal, FRM headshot

Genomics ETFs Surge on CRISPR's Gene Editing Progress

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

Sanghamitra Saha headshot

Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

Sweta Killa headshot

S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.